. Author manuscript; available in PMC: 2011 Jun 26.

Published in final edited form as: Behav Brain Res. 2010 Feb 21;210(1):116–122. doi: 10.1016/j.bbr.2010.02.030

Table 3.

Distance traveled immediately after saline or CGS21680/CPA administration (cm). A) 0.05/0.05mg/kg and B) 0.1/0.1mg/kg. Values expressed are group means with SEM in parentheses.

A
	Saline	0.05/0.05mg/kg CGS21680/CPA
30min post-injection	5801.8 (1026.8)	3479.7 (685.6)^*
1hr post-injection	11554.7 (1730.3)	8622.6 (1594.6)

B
	Saline	0.1/0.1mg/kg CGS21680/CPA
30min post-injection	6484.8 (722.9)	3520.4 (486.3)^*
1hr post-injection	14227.6 (1612.5)	6649.6 (927.4)^*

represents statistical significance at p<0.01 as compared to saline control group.